The digitalization of the healthcare ecosystem is also driving the digitalization of therapies. Digital Therapeutics (DTx) is not new, and they were already talked about as evidence-based clinical interventions that are delivered digitally. DTx is considered one of the most innovative areas within digital health and is forecasted to grow fivefold in the next three to five years.
The majority of DTx are targeting therapies for chronic diseases and neurological/psychiatric disorders. However, some challenges need to be addressed concerning the complexity and slowness of regulatory processes, reimbursement policies, stakeholder awareness & adoption, and narrowly defined product-centric business models to reach the full potential of DTx. There is a need to navigate these challenges and redefine the existing business model and market strategies. We will try to unlock these key aspects in the webinar.
We will cover :
Share your focus area or question to engage with our Analysts through the Business Objectives service.Submit My Business Objective
Our long-standing clients include some of the worlds leading brands and forward-thinking corporations.